Profile

MD, SUNY Downstate Medical Center
PhD, SUNY Downstate Medical Center




A Double-Blind, Randomized, Placebo-Conltolled Phase III Study to Assess the Efficiency of recMAGE-A3 + AS15 Antigens-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Non-Sm
07/03/2008 - 07/02/2012 (PI)
GlaxoSmithKline, Inc.


Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy other than Surgical Resection Alone for Newly Diagnosed Head and Neck Carcinoma
04/04/2008 - 12/31/2011 (PI)
ImClone Systems, Incorporated


A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of AMG 706 in Combination with Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
11/15/2007 - 12/31/2011 (PI)
Amgen, Inc.


An Open-Label, Multicenter, Randomized, Phase III Study Comparing Combination IV Topotecan/Docetaxel Alone in Second-Line Advanced (IIIB/IV) Non-Small-Cell Lung Cancer (NSCLC)
05/15/2006 - 05/14/2008 (PI)
Pfizer, Inc.

A Prospective Multi-Center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients with Progressive or Recurrent Glioblastoma Multiforme (GBM)
02/14/2007 - 02/14/2008 (Co-PI)
NovoCure, Ltd.

Phase II Randomized Open Label Trial of Biweekly Pemetrexed plus Gemcitabine vs. Pemetrexed or Pemetrexed plus Carboplatin in Relapsed
02/12/2007 - 02/11/2008 (PI)
Eli Lilly and Company, Lilly Research La


An Open-Label, Multicenter, Randomized, Phase III Study Comparing Combination IV Topotecan/Docetaxel Alone in Second-Line Advanced (IIIB/IV) Non-Small-Cell Lung Cancer (NSCLC)
05/12/2004 - 05/11/2005 (PI)
GlaxoSmithKline, Inc.

A Multicenter, Randomized, Phase III Study of Adjuvant Oncophage Versus Observation in Patients with High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma.
04/06/2001 - 07/31/2003 (Co-PI)
PI: Richard K. Babayan, MD
Antigenics Inc

An Open Label Single Arm Study of Intratumoral ONYX-015 Plus IV Cisplatin/5-FU in Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) Refractory to Cisplatin/5-FU
03/01/2002 - 02/28/2003 (PI)
Onyx Pharmaceuticals, Inc.

A Phase II Study of Weekly Gemcitabine and Paclitaxel for Advanced Non-Small Cell Carcinoma of the Lung
02/29/2000 - 12/31/2002 (Co-PI)
Brown University Eli Lilly and Co

Showing 10 of 12 results. Show All Results

A Lung Cancer Symptom Assessment and Management Intervention
06/18/2008 - 04/30/2013 (PI)
Dana Farber NIH-NCI



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Qureshi MM, Romesser PB, Jalisi S, Zaner KS, Cooley TP, Grillone G, Kachnic LA, Truong MT. The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer. Patient Educ Couns. 2014 Nov; 97(2):276-82.View Related Profiles. PMID: 25190640; DOI: 10.1016/j.pec.2014.07.031;.
  2. Cooley ME, Lobach DF, Johns E, Halpenny B, Saunders TA, Del Fiol G, Rabin MS, Calarese P, Berenbaum IL, Zaner K, Finn K, Berry DL, Abrahm JL. Creating computable algorithms for symptom management in an outpatient thoracic oncology setting. J Pain Symptom Manage. 2013 Dec; 46(6):911-924.e1.View Related Profiles. PMID: 23680580; PMCID: PMC4096777; DOI: 10.1016/j.jpainsymman.2013.01.016;.
  3. Cooley ME, Finn KT, Wang Q, Roper K, Morones S, Shi L, Litrownik D, Marcoux JP, Zaner K, Hayman LL. Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study. Cancer Nurs. 2013 Mar-Apr; 36(2):145-54. PMID: 22791213; DOI: 10.1097/NCC.0b013e31825e4359;.
  4. Daly BD, Ebright MI, Walkey AJ, Fernando HC, Zaner KS, Morelli DM, Kachnic LA. Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1392-7.View Related Profiles. PMID: 21281948; DOI: 10.1016/j.jtcvs.2010.12.011;.
  5. Nanda A, Dias-Santagata DC, Stubbs H, O''Hara CJ, Zaner KS, Lynch TJ, Willers H. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer. Clin Lung Cancer. 2008 Sep; 9(5):285-7.View Related Profiles. PMID: 18824451; DOI: 10.3816/CLC.2008.n.044;.
  6. Yi SK, Yoder M, Zaner K, Hirsch AE. Palliative radiation therapy of symptomatic recurrent bladder cancer. Pain Physician. 2007 Mar; 10(2):285-90.View Related Profiles. PMID: 17387350.
  7. Dragovich T, McCoy S, Fenoglio-Preiser CM, Wang J, Benedetti JK, Baker AF, Hackett CB, Urba SG, Zaner KS, Blanke CD, Abbruzzese JL. Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. J Clin Oncol. 2006 Oct 20; 24(30):4922-7. PMID: 17050876.
  8. Akerley W, Safran H, Zaner K, Ready N, Mega T, Kennedy T. Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer. Cancer. 2006 Sep 1; 107(5):1050-4. PMID: 16878327.
  9. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J. 2000 Oct 15; 351 Pt 2:449-58.View Related Profiles. PMID: 11023831; PMCID: PMC1221381.
  10. Guillaume T, Rubinstein DB, Zaner KS, Humblet Y, Symann M. Autologous peripheral blood stem cell transplantation for lung cancer. Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun; 12(1-2):233-46. PMID: 11000996.
Showing 10 of 44 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: